Skip to main content

Table 4 Univariate and multivariate regression analysis for predictors of achieving SVR

From: Outcome of direct-acting antiviral treatment in patients with hepatitis C virus/hepatitis B virus coinfection

 

Univariate

Multivariate

OR

95% CI

P value

OR

95% CI

P value

Age/year

1.977

0.910

3.050

0.026

1.655

1.232

2.212

 < 0.001

Gender

1.473

0.842

2.578

0.015

1.121

0.978

1.878

0.122

FBS (mg/dL)

1.121

0.877

1.822

0.072

    

HB (gm/dL)

1.299

0.740

2.281

0.161

    

WBCs (103/L)

1.418

0.667

3.016

0.164

    

PLT (103/L)

3.278

1.749

6.144

 < 0.001

1.241

0.544

2.829

0.008

ALT (U/L)

1.918

1.506

2.655

0.112

    

AST (U/L)

1.036

1.018

1.054

0.092

    

PC (%)

1.564

1.187

1.948

0.177

    

INR

1.298

0.741

2.231

0.099

    

Albumin (g/L)

1.243

0.670

1.502

0.09

    

Creatinine (mg/dL)

2.110

1.212

3.988

0.004

1.543

0.988

2.112

0.043

Liver stiffness (KPa)

5.992

2.432

7.670

 < 0.001

6.551

3.761

9.882

 < 0.001

Splenomegaly

2.321

1.198

3.211

0.034

1.071

0.547

1.566

0.542

HCV treatment

1.100

0.988

1.165

0.435

    

HCV RNA level at baseline

1.065

0.955

1.210

0.232

    
  1. OR Odds ratio, significant, FBS Fasting blood sugar, WBCs White blood cells, ALT Alanine aminotransferase, AST Aspartate aminotransferase, PC Prothrombin concentration, INR International normalized ratio, kPa Kilopascal, SVR Sustained virological response